Abstract: A plasma treatment method comprising exhausting a process chamber so as to decompress the process chamber, mounting a wafer on a suscepter, supplying a process gas to the wafer through a shower electrode, applying high frequency power, which has a first frequency f1 lower than an inherent lower ion transit frequencies of the process gas, to the suscepter, and applying high frequency power, which has a second frequency f2 higher than an inherent upper ion transit frequencies of the process gas, whereby a plasma is generated in the process chamber and activated species influence the wafer.

Abstract: Disclosed and claimed is a decorative computer pointer device for use in association with a computer. The computer pointer device includes a sealed decorative vessel containing a first liquid, a second liquid and at least one structure, wherein the structure is insoluble in both the first and the second liquids and floats on the first liquid. The first and the second liquids are advantageously immiscible. The first and the second liquids advantageously have densities such that the first liquid is beneath the second liquid, the first liquid, or the second liquid, or both of the first and the second liquids, are optionally colored or colorless. The structure suspended in the sealed vessel is advantageously weighted so it can maintain its upright configuration irrelevant to the position of the sealed vessel, and capable of remaining in suspension when the computer pointer device is in motion. The structure can also optionally be affixed in the decorative sealed vessel so as to remain substantially stationary.

Abstract: A plasma treatment method comprising exhausting a process chamber so as to decompress the process chamber, mounting a wafer on a suscepter, supplying a process gas to the wafer through a shower electrode, applying high frequency power, which has a first frequency f1 lower than an inherent lower ion transit frequencies of the process gas, to the suscepter, and applying high frequency power, which has a second frequency f2 higher than an inherent upper ion transit frequencies of the process gas, whereby a plasma is generated in the process chamber and activated species influence the wafer.

Abstract: The present invention relates to a container with a structural improvement. The improvement comprises one transparent hollow vessel, at least one circular dividing board and at least one reservoir for containing either liquid and/or solid, wherein the transparent hollow vessel has a first end and a second end, the first end further comprising a threaded sleeve, the second end of the transparent hollow vessel at an appropriate location having a water intake opening. The second end of the transparent hollow vessel is matingly-fitted with the circular dividing board, wherein the center of the circular dividing board has an opening to receive a dispensing tube, the dispensing tube positioned between the opening of the circular dividing board and the threaded sleeve of the first end of the transparent hollow vessel. The reservoir is matingly-fitted and positioned below the transparent hollow vessel.

Abstract: Claimed and disclosed is a sound emitting and dispensing device comprising a pressure-activated dispenser. The pressure-activated device has a top end with means for a user to apply pressure and engage the dispenser and dispense therefrom and a bottom end. The device according to the present invention also has a pedestal including a bottom end for sitting on a surface and a top end having means for optionally and removably receiving the bottom end of the pressure-activated dispenser, and a pressure-activated sound emitting device positioned in the meals for optionally removably receiving the bottom end of the pressure-activated dispenser. The pressure-activated dispenser is optionally removably connected to the pedestal and the pressure-activated sound emitting device is positioned beneath and in direct contact with the dispenser such that when the pressure-activated dispenser is so connected to the pedestal and pressure is applied to the top end of the dispenser, the sound emitting device is activated.

Abstract: Disclosed and claimed are: a composition including at least one glycosaminoglycan, e.g., CIS, and at least one alginate, e.g., sodium alginate, wherein: the at least one glycosaminoglycan and/or the algninate are cross-linked or polymerized, e.g., the alginate is cross-linked or polymerized, for instance by addition of an inorganic salt, such as a calcium salt; or the at least one glycosaminoglycan and the alginate are covalently bound, e.g., by means of a coupling reaction involving a linker molecule such as DVS; or the at least one glycosaminoglycan and/or the algninate are cross-linked or polymerized, e.g., the alginate is cross-linked or polymerized, for instance by addition of an inorganic salt, such as a calcium salt, and the at least one glycosaminoglycan and the alginate are covalently bound, e.g.

Abstract: A plasma treatment method comprising exhausting a process chamber so as to decompress the process chamber, mounting a wafer on a suscepter, supplying a process gas to the wafer through a shower electrode, applying high frequency power, which has a first frequency f1 lower than an inherent lower ion transit frequencies of the process gas, to the suscepter, and applying high frequency power, which has a second frequency f2 higher than an inherent upper ion transit frequencies of the process gas, whereby a plasma is generated in the process chamber and activated species influence the water.

Abstract: Non-immunogenic biocompatible macromolecular sheet composition are formed from a cellulosic membrane, a binding moiety having a plurality of functional groups, and a glycosaminoglycan (GAG). The binding moiety has the formula of R1—X—R2 wherein R1 and R2 are the same or different. The binding moiety, through functional groups binds the cellulosic membrane with the glycosaminoglycan. R1 is covalently bound to a carbon or an oxygen of the cellulosic membrane. R2 is covalently bound to a carbon, an oxygen, or a nitrogen of the glycosaminoglycan. The binding moiety can be bis-oxyrane, butanediol-diglycidyl ether (BDE), or divinyl sulfone. The cellulosic membrane can be a cellulosic membrane, partially acetylated cellulose and a copolymer of hydroxyethyl-methacrylate with methyl methacrylate, abbreviated as HEMA-MMA. The non-immunogenic biocompatible macromolecular sheet composition can be formed into a pouch to encapsulate cells, tissues, pharmaceuticals, or biological metabolic products.